Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

Summary

Our new report, “Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Genetic Testing market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within seven market categories – Inborn Gene or Chromosome Alterations, Other Genetic Tests and Acquired Gene or Chromosome Alterations. The report also provides company shares and distribution shares data for the overall Genetic Testing market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

- Market size data for Genetic Testing market categories – Inborn Gene or Chromosome Alterations, Other Genetic Tests and Acquired Gene or Chromosome Alterations
- Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the seven market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.
- 2011 company shares and distribution shares data for the overall Genetic Testing market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Genetic Testing market in BRICS.
- Key players covered include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthcare, Qiagen N.V., Bio-Rad Laboratories, Inc. and Gen-Probe Incorporated

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Genetic Testing competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize. SHOW LESS READ MORE >

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Genetic Testing in BRICS
3.1 Genetic Testing, BRICS, Overall Revenue ($m), USD Constant, 2004-2018
3.2 Genetic Testing, BRICS, Company share (2010-2011)
4 Genetic Testing In Brazil
4.1 Genetic Testing, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
4.2 Inborn Gene or Chromosome Alterations In Brazil
4.2.1 Inborn Gene or Chromosome Alterations, Brazil, Overall Revenue (2004-2018)
4.3 Other Genetic Tests In Brazil
4.3.1 Other Genetic Tests, Brazil, Overall Revenue (2004-2018)
4.4 Acquired Gene or Chromosome Alterations In Brazil
4.4.1 Acquired Gene or Chromosome Alterations, Brazil, Overall Revenue (2004-2018)
4.5 Genetic Testing, Brazil, Distribution Share (2010-2011)
4.6 Genetic Testing, Brazil, Company Share (2010-2011)
5 Genetic Testing In Russian Federation
5.1 Genetic Testing, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018
5.2 Inborn Gene or Chromosome Alterations In Russian Federation
5.2.1 Inborn Gene or Chromosome Alterations, Russian Federation, Overall Revenue (2004-2018)
5.3 Other Genetic Tests In Russian Federation
5.3.1 Other Genetic Tests, Russian Federation, Overall Revenue (2004-2018)
5.4 Acquired Gene or Chromosome Alterations In Russian Federation
5.4.1 Acquired Gene or Chromosome Alterations, Russian Federation, Overall Revenue (2004-2018)
5.5 Genetic Testing, Russian Federation, Distribution Share (2010-2011)
5.6 Genetic Testing, Russian Federation, Company Share (2010-2011)
6 Genetic Testing In India
6.1.1 Genetic Testing, India, Overall Revenue ($m), USD Constant, 2004-2018
6.2 Inborn Gene or Chromosome Alterations In India
6.2.1 Inborn Gene or Chromosome Alterations, India, Overall Revenue (2004-2018)
6.3 Other Genetic Tests In India
6.3.1 Other Genetic Tests, India, Overall Revenue (2004-2018)
6.4 Acquired Gene or Chromosome Alterations In India
6.4.1 Acquired Gene or Chromosome Alterations, India, Overall Revenue (2004-2018)
6.5 Genetic Testing, India, Distribution Share (2010-2011)
6.6 Genetic Testing, India, Company Share (2010-2011)
7 Genetic Testing In China
7.1 Genetic Testing, China, Overall Revenue ($m), USD Constant, 2004-2018
7.2 Inborn Gene or Chromosome Alterations In China
7.2.1 Inborn Gene or Chromosome Alterations, China, Overall Revenue (2004-2018)
7.3 Other Genetic Tests In China
7.3.1 Other Genetic Tests, China, Overall Revenue (2004-2018)
7.4 Acquired Gene or Chromosome Alterations In China
7.4.1 Acquired Gene or Chromosome Alterations, China, Overall Revenue (2004-2018)
7.5 Genetic Testing, China, Distribution Share (2010-2011)
7.6 Genetic Testing, China, Company Share (2010-2011)
8 Genetic Testing In South Africa
8.1 Genetic Testing, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
8.2 Inborn Gene or Chromosome Alterations In South Africa
8.2.1 Inborn Gene or Chromosome Alterations, South Africa, Overall Revenue (2004-2018)
8.3 Other Genetic Tests In South Africa
8.3.1 Other Genetic Tests, South Africa, Overall Revenue (2004-2018)
8.4 Acquired Gene or Chromosome Alterations In South Africa
8.4.1 Acquired Gene or Chromosome Alterations, South Africa, Overall Revenue (2004-2018)
8.5 Genetic Testing, South Africa, Distribution Share (2010-2011)
8.6 Genetic Testing, South Africa, Company Share (2010-2011)
9 Overview of Key Companies in BRICS Genetic Testing Market
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 Company Overview
9.1.2 Share in the BRICS Genetic Testing Market
9.2 Abbott Laboratories
9.2.1 Company Overview
9.2.2 Share in the BRICS Genetic Testing Market
9.3 Siemens Healthcare
9.3.1 Company Overview
9.3.2 Share in the BRICS Genetic Testing Market
9.4 Qiagen N.V.
9.4.1 Company Overview
9.4.2 Share in the BRICS Genetic Testing Market
9.5 Bio-Rad Laboratories, Inc.
9.5.1 Company Overview
9.5.2 Share in the BRICS Genetic Testing Market
9.6 Gen-Probe Incorporated
9.6.1 Company Overview
9.6.2 Share in the BRICS Genetic Testing Market
10 Appendix
10.1 Definitions of Markets Covered in the Report
10.1.1 Genetic Testing
10.2 Research Methodology
10.3 Secondary Research
10.4 Primary Research
10.5 Models
10.6 Forecasts
10.7 Expert Panels
10.8 Consulting
10.9 Currency Conversion
10.10 Contact Us
10.11 Disclaimer

1.1 List of Tables
Table 1: Genetic Testing, BRICS, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: Genetic Testing, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 3: Genetic Testing, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 4: Genetic Testing, BRICS, Company share by Revenue ($m), USD Constant, 2010-2011
Table 5: Genetic Testing, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
Table 6: Genetic Testing, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 7: Genetic Testing, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 8: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Table 9: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 10: Other Genetic Tests, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Table 11: Other Genetic Tests, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 12: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Table 13: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 14: Genetic Testing, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: Genetic Testing, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018
Table 17: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 18: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 19: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Table 20: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 21: Other Genetic Tests, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Table 22: Other Genetic Tests, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 23: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Table 24: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 25: Genetic Testing, Russian Federation, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 26: Genetic Testing, Russian Federation, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 27: Genetic Testing, India, Overall Revenue ($m), USD Constant, 2004-2018
Table 28: Genetic Testing, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 29: Genetic Testing, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 30: Inborn Gene or Chromosome Alterations, India, Revenue ($m), USD Constant, Historic, 2004-2011
Table 31: Inborn Gene or Chromosome Alterations, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 32: Other Genetic Tests, India, Revenue ($m), USD Constant, Historic, 2004-2011
Table 33: Other Genetic Tests, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 34: Acquired Gene or Chromosome Alterations, India, Revenue ($m), USD Constant, Historic, 2004-2011
Table 35: Acquired Gene or Chromosome Alterations, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 36: Genetic Testing, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 37: Genetic Testing, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 38: Genetic Testing, China, Overall Revenue ($m), USD Constant, 2004-2018
Table 39: Genetic Testing, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 40: Genetic Testing, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 41: Inborn Gene or Chromosome Alterations, China, Revenue ($m), USD Constant, Historic, 2004-2011
Table 42: Inborn Gene or Chromosome Alterations, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 43: Other Genetic Tests, China, Revenue ($m), USD Constant, Historic, 2004-2011
Table 44: Other Genetic Tests, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 45: Acquired Gene or Chromosome Alterations, China, Revenue ($m), USD Constant, Historic, 2004-2011
Table 46: Acquired Gene or Chromosome Alterations, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 47: Genetic Testing, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 48: Genetic Testing, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 49: Genetic Testing, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
Table 50: Genetic Testing, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 51: Genetic Testing, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 52: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Table 53: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 54: Other Genetic Tests, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Table 55: Other Genetic Tests, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 56: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Table 57: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 58: Genetic Testing, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 59: Genetic Testing, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 60: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Genetic Testing Market, 2011
Table 61: Abbott Laboratories, Revenue ($m), BRICS Genetic Testing Market, 2011
Table 62: Siemens Healthcare, Revenue ($m), BRICS Genetic Testing Market, 2011
Table 63: Qiagen N.V., Revenue ($m), BRICS Genetic Testing Market, 2011
Table 64: Bio-Rad Laboratories, Inc., Revenue ($m), BRICS Genetic Testing Market, 2011
Table 65: Gen-Probe Incorporated, Revenue ($m), BRICS Genetic Testing Market, 2011

1.2 List of Figures
Figure 1: Genetic Testing, BRICS, Overall Revenue ($m), USD Constant, 2004-2018
Figure 2: Genetic Testing, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 3: Genetic Testing, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 4: Genetic Testing, BRICS, Company share (%), 2011
Figure 5: Genetic Testing, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
Figure 6: Genetic Testing, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 7: Genetic Testing, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 8: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 9: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 10: Other Genetic Tests, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 11: Other Genetic Tests, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 12: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 13: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 14: Genetic Testing, Brazil, Company Share (%), 2011
Figure 15: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018
Figure 16: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 17: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 18: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m, USD Constant, Historic, 2004-2011
Figure 19: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 20: Other Genetic Tests, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 21: Other Genetic Tests, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 22: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 23: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 24: Genetic Testing, Russian Federation, Company Share (%), 2011
Figure 25: Genetic Testing, India, Overall Revenue ($m), USD Constant, 2004-2018
Figure 26: Genetic Testing, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 27: Genetic Testing, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 28: Inborn Gene or Chromosome Alterations, India, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 29: Inborn Gene or Chromosome Alterations, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 30: Other Genetic Tests, India, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 31: Other Genetic Tests, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 32: Acquired Gene or Chromosome Alterations, India, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 33: Acquired Gene or Chromosome Alterations, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 34: Genetic Testing, India, Company Share (%), 2011
Figure 35: Genetic Testing, China, Overall Revenue ($m), USD Constant, 2004-2018
Figure 36: Genetic Testing, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 37: Genetic Testing, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 38: Inborn Gene or Chromosome Alterations, China, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 39: Inborn Gene or Chromosome Alterations, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 40: Other Genetic Tests, China, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 41: Other Genetic Tests, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 42: Acquired Gene or Chromosome Alterations, China, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 43: Acquired Gene or Chromosome Alterations, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 44: Genetic Testing, China, Company Share (%), 2011
Figure 45: Genetic Testing, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
Figure 46: Genetic Testing, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 47: Genetic Testing, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 48: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 49: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 50: Other Genetic Tests, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 51: Other Genetic Tests, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 52: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 53: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 54: Genetic Testing, South Africa, Company Share (%), 2011
Figure 55: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Genetic Testing Market, 2011
Figure 56: Abbott Laboratories, Company Share (%), BRICS Genetic Testing Market, 2011
Figure 57: Siemens Healthcare, Company Share (%), BRICS Genetic Testing Market, 2011
Figure 58: Qiagen N.V., Company Share (%), BRICS Genetic Testing Market, 2011
Figure 59: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Genetic Testing Market, 2011
Figure 60: Gen-Probe Incorporated, Company Share (%), BRICS Genetic Testing Market, 2011

F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Siemens Healthcare
Qiagen N.V.
Bio-Rad Laboratories, Inc.
Gen-Probe Incorporated